Publications

Nature

Gene expression profiling predicts clinical outcome of breast cancer.

31-01-2002

Cancer letters

B-myb rescues ras-induced premature senescence, which requires its transactivation domain.

28-09-2001

Nature cell biology

Escape from premature senescence is not sufficient for oncogenic transformation by Ras.

01-02-2001

Oncogene

p27kip1-independent cell cycle regulation by MYC.

05-10-2000

Cell

Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.

07-07-2000

Oncogene

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

06-07-2000

Oncogene

The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.

16-03-2000

Biochimica et biophysica acta

CDK-independent activities of D type cyclins.

29-10-1999

Oncogene

Rapid dephosphorylation of p107 following UV irradiation.

21-01-1999

Oncogene

Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein.

14-01-1999

Genes & development

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

15-11-1998

Biochimica et biophysica acta

E2F: a nodal point in cell cycle regulation.

09-12-1997

Oncogene

Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.

01-09-1997

The Journal of biological chemistry

Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system.

22-08-1997

FEBS letters

Communication between the extracellular environment, cytoplasmic signalling cascades and the nuclear cell-cycle machinery.

23-06-1997

Cell

CDK-independent activation of estrogen receptor by cyclin D1.

07-02-1997

Genes & development

Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

01-12-1996

The Journal of biological chemistry

mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect.

18-10-1996

Biochimica et biophysica acta

Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

07-06-1996

Trends in genetics : TIG

Cycling in Switzerland.

01-04-1996

The Journal of biological chemistry

Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

08-03-1996

Science (New York, N.Y.)

rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint.

19-01-1996

Current biology : CB

Transcriptional regulation. Flipping the Myc switch.

01-08-1995

The EMBO journal

BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation.

03-07-1995

Genes & development

Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

01-06-1995

Molecular and cellular biology

E2F-5, a new E2F family member that interacts with p130 in vivo.

01-06-1995

Genes & development

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

15-11-1994

The EMBO journal

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

01-09-1994

Gene expression profiling predicts clinical outcome of breast cancer.

B-myb rescues ras-induced premature senescence, which requires its transactivation domain.

Escape from premature senescence is not sufficient for oncogenic transformation by Ras.

p27kip1-independent cell cycle regulation by MYC.

Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.

CDK-independent activities of D type cyclins.

Rapid dephosphorylation of p107 following UV irradiation.

Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein.

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.

E2F: a nodal point in cell cycle regulation.

Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.

Crystal structure of murine/human Ubc9 provides insight into the variability of the ubiquitin-conjugating system.

Communication between the extracellular environment, cytoplasmic signalling cascades and the nuclear cell-cycle machinery.

CDK-independent activation of estrogen receptor by cyclin D1.

Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.

mUBC9, a novel adenovirus E1A-interacting protein that complements a yeast cell cycle defect.

Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins.

Cycling in Switzerland.

Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.

rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint.

Transcriptional regulation. Flipping the Myc switch.

BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation.

Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

E2F-5, a new E2F family member that interacts with p130 in vivo.

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

This site uses cookies